New AI Technology by Covera Health enhances routine imaging for women’s health

WT default author logo
Women's Tabloid News Desk

Protect Her, an AI-powered platform from Covera Health, is intended to improve the early identification of serious medical diseases in women 40 years of age and older. The novel approach uses standard imaging, such as x-rays, chest CT scans, and mammograms, to find early indicators of osteoporosis, cardiovascular disease, and breast cancer before symptoms show up.

“Early detection is the single most powerful tool we have to improve health outcomes, particularly for women, who are frequently underdiagnosed in these areas,” said Ron Vianu, CEO of Covera Health. “Protect Her empowers providers with AI-powered insights that can detect serious and life-threatening conditions early, allowing women to get the right care before it’s too late. This is a game-changer for women’s health.”

The platform highlights a number of concerning data while addressing important gaps in women’s healthcare. Approximately one in two women with osteoporosis will suffer an osteoporotic fracture in their lifetime, up to one in six women exhibit early symptoms of heart disease on normal mammograms, and mammogram screenings fail to detect one in five breast cancers.

Dr. Phoebe E. Freer, a Professor of Radiology and Breast Cancer Screening Leader with the American College of Radiology, commented: “AI has the ability to transform how we practice medicine, especially when it comes to our ability to detect early signs of disease. By using advanced technology to analyze a patient’s image beyond the primary concern, we can detect high-impact conditions more readily, giving patients and their physicians critical insights that may help them act before a crisis occurs.”

Protect Her platform analyses routine imaging to identify early indications of vertebral spine fractures, coronary artery calcium on chest CT images, breast arterial calcifications as a marker of heart disease, and subtle patterns of breast cancer. Improved diagnostic accuracy, fewer expensive claims related to late-stage illnesses, more worker productivity, and cheaper long-term healthcare expenses are just a few of the many advantages the platform provides to companies and health plans.

Share:

Related Insights

Calla Lily Clinical Care selected for $50 million Wellcome Leap antibiotics initiative

Women scientists showcase market-ready innovations at Hanoi tech event

NVIDIA partners with global financial institutions to build AI compute financing platforms

Cross-Border Impact Ventures secures $58 million first close for second health technology fund

AMD agrees to acquire Canadian AI chip startup Taalas

DarioHealth expands chronic care platform with new women’s health and sleep solutions

iBio appoints endocrinologist Molly Carr as Chief Medical Officer

GE HealthCare launches new 3D breast ultrasound technology to improve supplemental screening